L. O. Gentry

528 total citations
12 papers, 415 citations indexed

About

L. O. Gentry is a scholar working on Infectious Diseases, Pharmacology and Epidemiology. According to data from OpenAlex, L. O. Gentry has authored 12 papers receiving a total of 415 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 5 papers in Pharmacology and 5 papers in Epidemiology. Recurrent topics in L. O. Gentry's work include Antibiotics Pharmacokinetics and Efficacy (5 papers), Respiratory and Cough-Related Research (3 papers) and Pneumonia and Respiratory Infections (2 papers). L. O. Gentry is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (5 papers), Respiratory and Cough-Related Research (3 papers) and Pneumonia and Respiratory Infections (2 papers). L. O. Gentry collaborates with scholars based in United States. L. O. Gentry's co-authors include Junichiro Mera, T.M. Williams, Rabih O. Darouiche, Dima Abi-Said, C. Karl, E. J. Anaissie, Dimitrios P. Kontoyiannis, Ömrüm Uzun, G P Bodey and Ethan A. Natelson and has published in prestigious journals such as Circulation, Clinical Infectious Diseases and CHEST Journal.

In The Last Decade

L. O. Gentry

12 papers receiving 370 citations

Peers

L. O. Gentry

EPIDE

ID

PHARM

ONCOL

SURGE

J. P. Bédos France

W D Kobasa United States

C Carbon France

J.M. Decazes France

Geoffrey K. Richards Canada

John L. Brusch United States

N Shinagawa Japan

C. H. Teoh-Chan Hong Kong

Jerome Santoro United States

Robert K. Pelz United States

J. P. Bédos France

L. O. Gentry

294 ×1.2

EPIDE

125 ×0.6

ID

101 ×1.1

PHARM

28 ×0.6

ONCOL

73 ×1.6

SURGE

Citations per year, relative to L. O. Gentry L. O. Gentry (= 1×) peers J. P. Bédos

Countries citing papers authored by L. O. Gentry

Since Specialization

Citations

This map shows the geographic impact of L. O. Gentry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. O. Gentry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. O. Gentry more than expected).

Fields of papers citing papers by L. O. Gentry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. O. Gentry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. O. Gentry. The network helps show where L. O. Gentry may publish in the future.

Co-authorship network of co-authors of L. O. Gentry

This figure shows the co-authorship network connecting the top 25 collaborators of L. O. Gentry. A scholar is included among the top collaborators of L. O. Gentry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. O. Gentry. L. O. Gentry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Anaissie, E. J., Rabih O. Darouiche, Dima Abi-Said, et al.. (1996). Management of Invasive Candidal Infections: Results of a Prospective, Randomized, Multicenter Study of Fluconazole Versus Amphotericin B and Review of the Literature. Clinical Infectious Diseases. 23(5). 964–972. 216 indexed citations

2.

Gentry, L. O.. (1993). Diagnosis and management of the diabetic foot ulcer. Journal of Antimicrobial Chemotherapy. 32(suppl A). 77–89. 14 indexed citations

3.

Gentry, L. O.. (1992). Therapy with Newer Oral -Lactam and Quinolone Agents for Infections of the Skin and Skin Structures: A Review. Clinical Infectious Diseases. 14(1). 285–297. 24 indexed citations

4.

Gentry, L. O.. (1990). Future developments in nosocomial infections: the perspective in the United States. Journal of Hospital Infection. 15. 3–12. 5 indexed citations

5.

Gentry, L. O.. (1987). Roxithromycin, a new macrolide antibiotic, in the treatment of infections in the lower respiratory tract: an overview. Journal of Antimicrobial Chemotherapy. 20(suppl B). 145–152. 19 indexed citations

6.

Gentry, L. O., et al.. (1985). Effects of apalcillin on platelet function in normal volunteers. Antimicrobial Agents and Chemotherapy. 27(5). 683–684. 7 indexed citations

7.

Gentry, L. O., et al.. (1981). In-vitro comparison of ceftazidime and nine other antimicrobial agents against hospital strains of Gram-negative bacteria. Journal of Antimicrobial Chemotherapy. 8(suppl B). 53–56. 13 indexed citations

8.

Gentry, L. O., Joseph G. Jemsek, & Ethan A. Natelson. (1981). Effects of sodium piperacillin on platelet function in normal volunteers. Antimicrobial Agents and Chemotherapy. 19(4). 532–533. 45 indexed citations

9.

Finegold, S M, L. O. Gentry, W. J. Mogabgab, Sammy C. Campbell, & James B. Skatrud. (1981). Controlled Comparative Trial of Bacampicillin and Amoxicillin in Therapy of Bacterial Infections of the Lower Respiratory Tract. Clinical Infectious Diseases. 3(1). 150–153. 10 indexed citations

10.

Young, James B., et al.. (1979). Recurrent Infective Endocarditis in a Drug Addict. CHEST Journal. 76(5). 592–594. 8 indexed citations

11.

Young, James B., David E. Welton, Albert E. Raizner, et al.. (1979). Surgery in active infective endocarditis.. Circulation. 60(2). 77–81. 43 indexed citations

12.

Gentry, L. O.. (1978). Efficacy and Safety of Cefamandole plus either Gentamicin or Tobramycin in Therapy of Severe Gram-Negative Bacterial Infections. The Journal of Infectious Diseases. 137(Supplement). S144–S149. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact